new! Lorcaserin -- The Complete Panel Transcript
2003 FDA Advisory Panel: Obesity Epidemic & Critical Path Forward
2004 FDA Advisory Panel: Revisions to Original 1996 Guidance
Lorcaserin - FDA Briefing Documents (pdf)
Qnexa - FDA Briefing Documents (pdf)
Qnexa - Advisory Panel Transcript (pdf)
Lorcaserin: A novel, selective 5-HT2C-receptor agonist for the treatment of obesity
Other Blogs
Never Trust the Street
Arenadeepcapture
